Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity

European Journal of Surgical Oncology

Volumn 34, Issue 2, 2008, Pages 208-215

  Kim, S Y ^a   Roh, J L ^a   Kim, J S ^a   Ryu, C H ^a   Lee, J H ^a   Cho, K J ^a   Choi, S H ^a   Nam, S Y ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Oral cavity; Squamous cell carcinoma; Staging; Standardized uptake value; Surveillance

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DRUG UPTAKE; FEMALE; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH CAVITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NECK METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 38149079846     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.015     Document Type: Article

References (27)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Tankere F., Camproux A., Barry B., Guedon C., Depondt J., and Gehanno P. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 110 (2000) 2061-2065
3. Kowalski L.P., Bagietto R., Lara J.R., Santos R.L., Silva Jr. J.F., and Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22 (2000) 207-214
4. Layland M.K., Sessions D.G., and Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 115 (2005) 629-639
5. Hao S.P., and Ng S.H. Magnetic resonance imaging versus clinical palpation in evaluating cervical metastasis from head and neck cancer. Otolaryngol Head Neck Surg 123 (2000) 324-327
6. Castelijns J.A., and van den Brekel M.W. Imaging of lymphadenopathy in the neck. Eur Radiol 12 (2002) 727-738
7. Adams S., Baum R.P., Stuckensen T., Bitter K., and Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 (1998) 1255-1260
8. Ng S.H., Yen T.C., Chang J.T., et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24 (2006) 4371-4376
9. Schoder H., Carlson D.L., Kraus D.H., et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 (2006) 755-762
10. Ng S.H., Yen T.C., Liao C.T., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46 (2005) 1136-1143
11. Stoeckli S.J., Steinert H., Pfaltz M., and Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24 (2002) 345-349
12. Som P.M., Curtin H.D., and Mancuso A.A. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 174 (2000) 837-844
13. Fukui M.B., Blodgett T.M., Snyderman C.H., et al. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics 25 (2005) 913-930
14. Hyde N.C., Prvulovich E., Newman L., Waddington W.A., Visvikis D., and Ell P. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39 (2003) 350-360
15. Fortin A., Couture C., Doucet R., Albert M., Allard J., and Tetu B. Does histologic grade have a role in the management of head and neck cancers?. J Clin Oncol 19 (2001) 4107-4116
16. Goerres G.W., Schmid D.T., Schuknecht B., and Eyrich G.K. Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT. Radiology 237 (2005) 281-287
17. Hiratsuka H., Miyakawa A., Nakamori K., Kido Y., Sunakawa H., and Kohama G. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 80 (1997) 351-356
18. Haddadin K.J., Soutar D.S., Oliver R.J., Webster M.H., Robertson A.G., and MacDonald D.G. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 21 (1999) 517-525
19. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38 (1997) 1907-1911
20. Allal A.S., Slosman D.O., Kebdani T., Allaoua M., Lehmann W., and Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
21. Allal A.S., Dulguerov P., Allaoua M., et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 (2002) 1398-1404
22. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
23. Ryan W.R., Fee Jr. W.E., Le Q.T., and Pinto H.A. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115 (2005) 645-650
24. Kunkel M., Forster G.J., Reichert T.E., et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 98 (2003) 2257-2265
25. Choi J.Y., Lee K.S., Kwon O.J., et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 23 (2005) 7654-7659
26. Al-Rajhi N., Khafaga Y., El-Husseiny J., et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 36 (2000) 508-514
27. Sessions D.G., Spector G.J., Lenox J., Haughey B., Chao C., and Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 112 (2002) 616-625